Percutaneous microwave ablation versus sclerotherapy for large hepatic hemangioma: a multi-center cohort study

References

• Belghiti J, Cauchy F, Paradis V, et al. Diagnosis and management of solid benign liver lesions. Nat Rev Gastroenterol Hepatol. 2014;11(12):737–749. doi: 10.1038/nrgastro.2014.151.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver (EASL). EASL clinical practice guidelines on the management of benign liver tumours. J Hepatol. 2016;65:386–398. doi: 10.1016/j.jhep.2016.04.001.
   PubMed Web of Science ®Google Scholar
• Marrero JA, Ahn J, Rajender Reddy K. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol. 2014;109(9):1328–1347; quiz 1348. doi: 10.1038/ajg.2014.213.
   PubMed Web of Science ®Google Scholar
• Pompili M, Ardito F, Brunetti E, et al. Benign liver lesions 2022: guideline for clinical practice of associazione italiana studio del fegato (AISF), società italiana di radiologia medica e interventistica (SIRM), società italiana di chirurgia (SIC), società italiana di ultrasonologia in medicina e biologia (SIUMB), associazione italiana di chirurgia Epatobilio-Pancreatica (AICEP), società italiana trapianti d‘Organo (SITO), società italiana di anatomia patologica e citologia diagnostica (SIAPEC-IAP) - Part II - solid lesions. Dig Liver Dis. 2022;54(12):1614–1622. doi: 10.1016/j.dld.2022.08.031.
   PubMedGoogle Scholar
• Li X, An C, Liu F, et al. The value of 3d visualization operative planning system in ultrasound-guided percutaneous microwave ablation for large hepatic hemangiomas: a clinical comparative study. BMC Cancer. 2019;19(1):550. doi: 10.1186/s12885-019-5682-5.
   Google Scholar
• Ayoobi Yazdi N, Mehrabinejad M-M, Dashti H, et al. Percutaneous sclerotherapy with bleomycin and ethiodized oil: a promising treatment in symptomatic giant liver hemangioma. Radiology. 2021;301(2):464–471. doi: 10.1148/radiol.2021204444.
   PubMed Web of Science ®Google Scholar
• Dong W, Qiu B, Xu H, et al. Invasive management of symptomatic hepatic hemangioma. Eur J Gastroenterol Hepatol. 2019;31(9):1079–1084. doi: 10.1097/MEG.0000000000001413.
   PubMed Web of Science ®Google Scholar
• Giuliante F, Ardito F, Vellone M, et al. Reappraisal of surgical indications and approach for liver hemangioma: single-center experience on 74 patients. Am J Surg. 2011;201(6):741–748. doi: 10.1016/j.amjsurg.2010.03.007.
   PubMed Web of Science ®Google Scholar
• Miura JT, Amini A, Schmocker R, et al. Surgical management of hepatic hemangiomas: a multi-institutional experience. HPB. 2014;16(10):924–928. doi: 10.1111/hpb.12291.
   PubMed Web of Science ®Google Scholar
• Clarke DL, Currie EJ, Madhavan KK, et al. Hepatic resection for benign non-cystic liver lesions. HPB. 2004;6(2):115–119. doi: 10.1080/13651820410026326.
   PubMedGoogle Scholar
• Shi Y, Song J, Ding M, et al. Microwave ablation versus transcatheter arterial embolization for large hepatic hemangiomas: clinical outcomes. Int J Hyperthermia. 2020;37(1):938–943. doi: 10.1080/02656736.2020.1766122.
   PubMed Web of Science ®Google Scholar
• Liu F, Yu X, Liang P, et al. Ultrasonography-guided percutaneous microwave ablation for large hepatic cavernous haemangiomas. Int J Hyperthermia. 2018;34(7):1061–1066. doi: 10.1080/02656736.2017.1392045.
   PubMed Web of Science ®Google Scholar
• Jin S, Shi X, Sun X, et al. Sclerosing cholangitis secondary to bleomycin-iodinated embolization for liver hemangioma. World J Gastroenterol. 2014;20(46):17680–17685. doi: 10.3748/wjg.v20.i46.17680.
   PubMed Web of Science ®Google Scholar
• Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693. doi: 10.1016/j.jhep.2021.11.018.
   PubMed Web of Science ®Google Scholar
• Park S, Tak W, Jung M, et al. Symptomatic-enlarging hepatic hemangiomas are effectively treated by percutaneous ultrasonography-guided radiofrequency ablation. J Hepatol. 2011;54(3):559–565. doi: 10.1016/j.jhep.2010.07.024.
   PubMed Web of Science ®Google Scholar
• Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol. 2004;15(5):431–445. doi: 10.1097/01.rvi.0000124949.24134.cf.
   PubMed Web of Science ®Google Scholar
• Ayoobi Yazdi N, Dashti H, Batavani N, et al. Percutaneous sclerotherapy for giant symptomatic liver hemangiomas: a pilot study. J Vasc Interv Radiol. 2018;29(2):233–236. doi: 10.1016/j.jvir.2017.10.009.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273(1):241–260. doi: 10.1148/radiol.14132958.
   PubMed Web of Science ®Google Scholar
• Sacks D, McClenny TE, Cardella JF, et al. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):S199–S202. doi: 10.1097/01.rvi.0000094584.83406.3e.
   PubMed Web of Science ®Google Scholar
• Nevesny F, Chevallier O, Falvo N, et al. Bleomycin for percutaneous sclerotherapy of venous and lymphatic malformations: a retrospective study of safety, efficacy and mid-term outcomes in 26 patients. J Clin Med. 2021;10(6):1302. doi: 10.3390/jcm10061302.
   PubMed Web of Science ®Google Scholar
• Muir T, Kirsten M, Fourie P, et al. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int. 2004;19(12):766–773. doi: 10.1007/s00383-003-1058-6.
   PubMed Web of Science ®Google Scholar
• O'Sullivan JM, Huddart RA, Norman AR, et al. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann Oncol. 2003;14(1):91–96. doi: 10.1093/annonc/mdg020.
   PubMed Web of Science ®Google Scholar
• Horbach S, Rigter I, Smitt J, et al. Intralesional bleomycin injections for vascular malformations: a systematic review and meta-analysis. Plast Reconstr Surg. 2016;137(1):244–256. doi: 10.1097/PRS.0000000000001924.
   PubMed Web of Science ®Google Scholar
• Furumaya A, van Rosmalen BV, Takkenberg RB, et al. Transarterial (chemo-)embolization and lipiodolization for hepatic haemangioma. Cardiovasc Intervent Radiol. 2019;42(6):800–811. doi: 10.1007/s00270-019-02169-x.
   PubMed Web of Science ®Google Scholar